PHARM Connect Congress is the largest and most important pharmaceutical and biotechnology business summit in the Central Eastern European region. With its 500+ participants from over 25 countries in the region and beyond, the Congress – to be held for the tenth time on 10-11 March 2020 – is a great platform to benchmark and network with an exclusive group of senior peers. We are here to help and accelerate the effectiveness of your marketing strategies, maximise ROI and stay ahead of the competition.
In order to ensure the quality of the conference programme, we work closely together with leading local and regional associations, European and global media partners and our Programme Advisory Committee, whose members are well-known pharmaceutical and biopharmaceutical industry experts of leading international companies. The conference programme offers the most up-to-date market insights into research and development, production, engineering, supply chain and quality management related topics.
Our event presents a unique opportunity to establish and develop fruitful, long-term and valuable business relations. Leading service providers of the pharmaceutical and biotechnology sector – covering a wide range of profiles from API’s and contract manufacturing to processing, biopharma solutions, biopharmaceuticals and biologicals, drug delivery systems, clean rooms, laboratory equipment, monitoring & inspection systems, quality control, packaging and labelling, automation, plant engineering and maintenance, logistics, cold chain storage and distribution, warehousing and many others – have the opportunity to meet the key decision makers of their targeted companies.
At TEG, we understand how challenging it is to find the right person, from each company at a time when they are ready to invest. We are experts in supporting companies to increase their ROI, reducing sales cycles and accelerating the time-to-market.
PHARM Connect invites only senior decision makers with a purchasing power who are looking to invest into new services and solutions.
Click here for more information